MDSpire - Summary
FDA & Government News

Inside Access, Outside the Rules

Two federal cases highlight alleged misuse of professional roles in health care settings

Share

Logan Marshall Abbott, a Kansas pharmacist, has been indicted for allegedly diverting controlled substances, including Adderall and oxycodone, from his employer. The Drug Enforcement Administration is investigating the case following Abbott's indictment on charges of acquiring a controlled substance by deception. Separately, Christopher Harwood, a telemedicine company owner, pleaded guilty to a $46.2 million Medicare fraud scheme that exploited billing processes. This scheme involved recruiting patients for unnecessary medical items through deceptive practices. Both cases illustrate significant risks of diversion and fraud in the healthcare system.

Original Source(s)

Inside Access, Outside the Rules

  • by Kerri Miller

  • April 1, 2026

Related Content

Fluvoxamine Reduces Long COVID Fatigue in Trial

A randomized, placebo-controlled trial found the selective serotonin reuptake inhibitor improved fatigue severity vs placebo, while metformin showed no evidence of benefit.

Side Effects: Variety Is Overrated

The organ you forgot, the cells that age unevenly, the AI that admits ignorance, and the diet advice that sounds wrong but isn't: medicine's next moves are hiding in plain sight.

Tirzepatide Linked to Greater QoL Gains vs Dulaglutide

Both groups improved, with numerically larger gains in patient-reported outcomes following a switch to tirzepatide